Eledon Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Eledon Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Eledon Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $621K, a 12.3% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $621K +$68K +12.3% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $270K -$377K -58.3% Mar 31, 2024 10-Q/A 2024-08-19
Q4 2023 $365K -$374K -50.6% Dec 31, 2023 10-Q 2024-08-19
Q3 2023 $459K -$373K -44.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $553K -$28K -4.82% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $647K -$28K -4.15% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $739K -$29K -3.78% Dec 31, 2022 10-K/A 2024-08-19
Q3 2022 $832K +$610K +275% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $581K +$314K +118% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $675K +$583K +634% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $768K +$630K +457% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $222K +$39K +21.3% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $267K +$39K +17.1% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $92K -$180K -66.2% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $138K -$178K -56.3% Dec 31, 2020 10-K 2022-03-24
Q3 2020 $183K -$177K -49.2% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $228K -$175K -43.4% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $272K -$174K -39% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $316K Dec 31, 2019 10-K 2021-03-31
Q3 2019 $360K Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $403K Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $446K Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.